Previous Close | 17.76 |
Open | 17.90 |
Bid | 16.96 x 1400 |
Ask | 18.19 x 1000 |
Day's Range | 16.86 - 18.21 |
52 Week Range | 11.71 - 41.60 |
Volume | 2407373 |
Avg. Volume | 2,517,079 |
Market Cap | 2.8B |
Beta (5Y Monthly) | 2.46 |
PE Ratio (TTM) | 7.09 |
EPS (TTM) | 2.39 |
Earnings Date | Feb 12, 2020 - Feb 17, 2020 |
Forward Dividend & Yield | 1.00 (5.63%) |
Ex-Dividend Date | 2019-11-14 |
1y Target Est | 24.23 |
NEW YORK, NY / ACCESSWIRE / December 9, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against The Chemours Company
SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2019 / Hagens Berman alerts The Chemours Company (NYSE:CC) investors of today's deadline to move for lead plaintiff in a securities fraud class action pending ...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until December 9, 2019 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased the Company's shares between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
SAN FRANCISCO, CA / ACCESSWIRE / December 8, 2019 / Hagens Berman urges The Chemours Company (NYSE:CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit ...
SAN FRANCISCO, CA / ACCESSWIRE / December 7, 2019 / Hagens Berman urges The Chemours Company (NYSE:CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit ...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until December 9, 2019 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased the Company’s shares between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
SAN FRANCISCO, Dec. 06, 2019 -- Hagens Berman urges The Chemours Company (NYSE: CC) investors who have suffered significant losses on Chemours common stock, options and/or.
LOS ANGELES, CA / ACCESSWIRE / December 6, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. If you are a shareholder who suffered a loss, click here to participate.
NEW YORK, NY / ACCESSWIRE / December 6, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. According to the filed complaint, during the class period, ADTRAN, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company's internal control over financial reporting; (2) as a result, certain E&O reserves had been improperly reported; (3) as a result, the Company's financial results for certain periods were misstated; (4) there would be a pause in shipments to the Company's Latin American customer; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
A look at a position the hedge fund manager was buying in the third quarter Continue reading...
New York, New York--(Newsfile Corp. - December 6, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in The Chemours Company (NYSE: CC) ("Chemours" or the "Company") of the December 9, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi logoIf you invested in Chemours stock or options between February 16, 2017 and ...
NEW YORK, NY / ACCESSWIRE / December 6, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. Allegations against CC include that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company's policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours' handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or the “Company”) (CC) and certain of its officers, on behalf of shareholders who purchased Chemours securities between February 16, 2017 and August 1, 2019 (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. The Complaint alleges that, throughout the Class Period, Defendants misled investors by representing that Chemours had appropriately accounted and accrued reserves for its environmental liabilities, that the possibility of costs exceeding accrued amounts was "remote," and that, in any event, additional costs would not be material.
Hagens Berman urges The Chemours Company (NYSE: CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit their loss now to learn if they qualify to recover their investment losses. The December 9, 2019 lead plaintiff deadline in a securities fraud class action pending against the company is fast approaching.
LOS ANGELES, CA / ACCESSWIRE / December 5, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. If you are a shareholder who suffered a loss, click here to participate.
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. In July 2015, Chemours became public via a spinoff of the Performance Chemicals division of E.I. du Pont de Nemours and Company (“DuPont”).
NEW ORLEANS, Dec. 04, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
SAN FRANCISCO, CA / ACCESSWIRE / December 4, 2019 / Hagens Berman urges The Chemours Company (NYSE:CC) investors who have suffered significant losses to submit their loss now to learn if they qualify to ...
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ...
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (CC) and certain of its officers. The class action, filed in United States District Court, for the District of Delaware, and docketed under 19-cv-02074, is on behalf of a class consisting of investors who purchased or otherwise Chemours securities between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). The claims asserted herein are alleged against Chemours and certain of the Company's senior executives (collectively, "Defendants"), and arise under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and the rules promulgated thereunder, including SEC Rule 10b-5, 17 C.F.R. § 240.10b-5.
LOS ANGELES, CA / ACCESSWIRE / December 4, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2017 and August 1, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before December 9, 2019.
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a ...